Orthofix Medical Inc. (OFIX)
USD 13.92
(-5.43%)
USD 13.92
(-5.43%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 96.44 Million USD | 413.03% |
| 2022 | -30.8 Million USD | 52.87% |
| 2021 | -65.36 Million USD | 8.39% |
| 2020 | -71.35 Million USD | -46.37% |
| 2019 | -48.74 Million USD | 29.98% |
| 2018 | -69.62 Million USD | 14.21% |
| 2017 | -81.15 Million USD | -105.09% |
| 2016 | -39.57 Million USD | 37.84% |
| 2015 | -63.66 Million USD | -72.93% |
| 2014 | -36.81 Million USD | -251.09% |
| 2013 | -10.48 Million USD | 5.01% |
| 2012 | -11.03 Million USD | -106.24% |
| 2011 | 176.8 Million USD | -14.36% |
| 2010 | 206.44 Million USD | -14.46% |
| 2009 | 241.34 Million USD | -10.0% |
| 2008 | 268.17 Million USD | -4.76% |
| 2007 | 281.57 Million USD | -2.77% |
| 2006 | 289.58 Million USD | 697.1% |
| 2005 | -48.49 Million USD | -194.29% |
| 2004 | 51.43 Million USD | -32.89% |
| 2003 | 76.64 Million USD | 285.17% |
| 2002 | -41.39 Million USD | -44.16% |
| 2001 | -28.71 Million USD | 27.57% |
| 2000 | -39.64 Million USD | -976.22% |
| 1999 | 4.52 Million USD | 74.0% |
| 1998 | 2.6 Million USD | -83.95% |
| 1997 | 16.2 Million USD | -9.5% |
| 1996 | 17.9 Million USD | 32.59% |
| 1995 | 13.5 Million USD | 175.84% |
| 1994 | -17.8 Million USD | -23.61% |
| 1993 | -14.4 Million USD | -17.07% |
| 1992 | -12.3 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 127.47 Million USD | -0.18% |
| 2024 Q1 | 127.7 Million USD | 32.42% |
| 2023 Q3 | 55.74 Million USD | 3.4% |
| 2023 Q1 | 14.76 Million USD | 147.92% |
| 2023 FY | 96.44 Million USD | 413.03% |
| 2023 Q2 | 53.91 Million USD | 265.14% |
| 2023 Q4 | 96.44 Million USD | 73.01% |
| 2022 Q4 | -30.8 Million USD | 2.55% |
| 2022 Q1 | -51.57 Million USD | 21.1% |
| 2022 FY | -30.8 Million USD | 52.87% |
| 2022 Q2 | -39.34 Million USD | 23.72% |
| 2022 Q3 | -31.61 Million USD | 19.64% |
| 2021 Q1 | -71.77 Million USD | -0.59% |
| 2021 Q4 | -65.36 Million USD | -8.77% |
| 2021 Q3 | -60.09 Million USD | -5.02% |
| 2021 FY | -65.36 Million USD | 8.39% |
| 2021 Q2 | -57.22 Million USD | 20.27% |
| 2020 Q3 | -56.84 Million USD | -13.85% |
| 2020 Q1 | -34.91 Million USD | 28.38% |
| 2020 Q2 | -49.93 Million USD | -43.03% |
| 2020 Q4 | -71.35 Million USD | -25.51% |
| 2020 FY | -71.35 Million USD | -46.37% |
| 2019 Q3 | -35.78 Million USD | -15.47% |
| 2019 Q1 | -25.43 Million USD | 63.47% |
| 2019 FY | -48.74 Million USD | 29.98% |
| 2019 Q4 | -48.74 Million USD | -36.21% |
| 2019 Q2 | -30.99 Million USD | -21.88% |
| 2018 Q1 | -77.05 Million USD | 5.05% |
| 2018 Q4 | -69.62 Million USD | -29.45% |
| 2018 Q2 | -45.68 Million USD | 40.71% |
| 2018 Q3 | -53.78 Million USD | -17.72% |
| 2018 FY | -69.62 Million USD | 14.21% |
| 2017 Q3 | -53.92 Million USD | -21.64% |
| 2017 FY | -81.15 Million USD | -105.09% |
| 2017 Q1 | -41.65 Million USD | -5.26% |
| 2017 Q2 | -44.33 Million USD | -6.43% |
| 2017 Q4 | -81.15 Million USD | -50.5% |
| 2016 Q2 | -40.48 Million USD | -1.6% |
| 2016 Q3 | -46.82 Million USD | -15.67% |
| 2016 FY | -39.57 Million USD | 37.84% |
| 2016 Q4 | -39.57 Million USD | 15.49% |
| 2016 Q1 | -39.84 Million USD | 37.41% |
| 2015 Q4 | -63.66 Million USD | 0.05% |
| 2015 Q1 | -29.78 Million USD | 19.1% |
| 2015 FY | -63.66 Million USD | -72.93% |
| 2015 Q3 | -63.69 Million USD | -13.85% |
| 2015 Q2 | -55.94 Million USD | -87.84% |
| 2014 Q2 | -8.91 Million USD | -32.19% |
| 2014 Q3 | -29.82 Million USD | -234.4% |
| 2014 Q1 | -6.74 Million USD | 35.66% |
| 2014 FY | -36.81 Million USD | -251.09% |
| 2014 Q4 | -36.81 Million USD | -23.44% |
| 2013 FY | -10.48 Million USD | 5.01% |
| 2013 Q3 | -2.21 Million USD | 69.89% |
| 2013 Q2 | -7.37 Million USD | 46.11% |
| 2013 Q1 | -13.67 Million USD | -23.88% |
| 2013 Q4 | -10.48 Million USD | -372.56% |
| 2012 Q1 | 159.31 Million USD | -9.89% |
| 2012 Q3 | -33.29 Million USD | -247.13% |
| 2012 Q4 | -11.03 Million USD | 66.84% |
| 2012 FY | -11.03 Million USD | -106.24% |
| 2012 Q2 | -9.59 Million USD | -106.02% |
| 2011 Q4 | 176.8 Million USD | -4.28% |
| 2011 FY | 176.8 Million USD | -14.36% |
| 2011 Q3 | 184.7 Million USD | -2.06% |
| 2011 Q2 | 188.59 Million USD | -2.57% |
| 2011 Q1 | 193.57 Million USD | -6.23% |
| 2010 Q4 | 206.44 Million USD | -1.63% |
| 2010 Q2 | 209.85 Million USD | -2.81% |
| 2010 FY | 206.44 Million USD | -14.46% |
| 2010 Q1 | 215.92 Million USD | -10.53% |
| 2010 Q3 | 209.87 Million USD | 0.01% |
| 2009 Q2 | 261.4 Million USD | -0.19% |
| 2009 Q3 | 255.27 Million USD | -2.35% |
| 2009 Q4 | 241.34 Million USD | -5.46% |
| 2009 FY | 241.34 Million USD | -10.0% |
| 2009 Q1 | 261.89 Million USD | -2.34% |
| 2008 Q1 | 277.51 Million USD | -1.44% |
| 2008 Q2 | 283.97 Million USD | 2.33% |
| 2008 Q4 | 268.17 Million USD | -6.76% |
| 2008 Q3 | 287.61 Million USD | 1.28% |
| 2008 FY | 268.17 Million USD | -4.76% |
| 2007 FY | 281.57 Million USD | -2.77% |
| 2007 Q1 | 291.48 Million USD | 0.66% |
| 2007 Q2 | 302.66 Million USD | 3.83% |
| 2007 Q3 | 293.7 Million USD | -2.96% |
| 2007 Q4 | 281.57 Million USD | -4.13% |
| 2006 Q3 | 296.16 Million USD | 742.17% |
| 2006 FY | 289.58 Million USD | 697.1% |
| 2006 Q2 | -46.11 Million USD | 4.73% |
| 2006 Q1 | -48.4 Million USD | 0.19% |
| 2006 Q4 | 289.58 Million USD | -2.22% |
| 2005 Q1 | 43.34 Million USD | -15.74% |
| 2005 Q4 | -48.49 Million USD | -20.76% |
| 2005 Q2 | 41.14 Million USD | -5.07% |
| 2005 Q3 | -40.16 Million USD | -197.62% |
| 2005 FY | -48.49 Million USD | -194.29% |
| 2004 Q3 | 55.27 Million USD | -9.62% |
| 2004 Q4 | 51.43 Million USD | -6.95% |
| 2004 Q2 | 61.16 Million USD | -11.25% |
| 2004 Q1 | 68.91 Million USD | -10.09% |
| 2004 FY | 51.43 Million USD | -32.89% |
| 2003 Q2 | -35.66 Million USD | 0.28% |
| 2003 Q1 | -35.76 Million USD | 13.6% |
| 2003 Q4 | 76.64 Million USD | 281.92% |
| 2003 FY | 76.64 Million USD | 285.17% |
| 2003 Q3 | -42.13 Million USD | -18.14% |
| 2002 Q2 | -33.13 Million USD | -21.17% |
| 2002 Q4 | -41.39 Million USD | -22.57% |
| 2002 FY | -41.39 Million USD | -44.16% |
| 2002 Q3 | -33.77 Million USD | -1.91% |
| 2002 Q1 | -27.34 Million USD | 4.75% |
| 2001 Q2 | -38.96 Million USD | -3.12% |
| 2001 FY | -28.71 Million USD | 27.57% |
| 2001 Q4 | -28.71 Million USD | 0.0% |
| 2001 Q1 | -37.78 Million USD | 4.67% |
| 2000 FY | -39.64 Million USD | -976.22% |
| 2000 Q1 | -46.86 Million USD | -1135.94% |
| 2000 Q2 | -49.62 Million USD | -5.89% |
| 2000 Q3 | -45.56 Million USD | 8.18% |
| 2000 Q4 | -39.64 Million USD | 13.01% |
| 1999 Q4 | 4.52 Million USD | 138.11% |
| 1999 Q2 | 5.7 Million USD | 714.29% |
| 1999 Q3 | 1.9 Million USD | -66.67% |
| 1999 FY | 4.52 Million USD | 74.0% |
| 1999 Q1 | 700 Thousand USD | -73.08% |
| 1998 Q4 | 2.6 Million USD | 0.0% |
| 1998 FY | 2.6 Million USD | -83.95% |
| 1997 FY | 16.2 Million USD | -9.5% |
| 1997 Q4 | 16.2 Million USD | 0.0% |
| 1996 Q4 | 17.9 Million USD | 0.0% |
| 1996 FY | 17.9 Million USD | 32.59% |
| 1995 Q4 | 13.5 Million USD | 0.0% |
| 1995 Q1 | -20.7 Million USD | -16.29% |
| 1995 FY | 13.5 Million USD | 175.84% |
| 1994 Q4 | -17.8 Million USD | 0.0% |
| 1994 Q2 | -14.8 Million USD | 0.0% |
| 1994 FY | -17.8 Million USD | -23.61% |
| 1993 FY | -14.4 Million USD | -17.07% |
| 1993 Q4 | -14.4 Million USD | 0.0% |
| 1992 Q4 | -12.3 Million USD | 0.0% |
| 1992 FY | -12.3 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -256.111% |
| Sight Sciences, Inc. | -102.71 Million USD | 193.893% |
| TELA Bio, Inc. | -3.94 Million USD | 2542.188% |
| Acutus Medical, Inc. | 12.27 Million USD | -685.422% |
| Talis Biomedical Corporation | -57.06 Million USD | 269.007% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -7448.466% |
| Bioventus Inc. | 372.51 Million USD | 74.11% |
| BrainsWay Ltd. | -10.32 Million USD | 1034.516% |
| Envoy Medical, Inc. | -3.81 Million USD | 2628.631% |
| CVRx, Inc. | -59.95 Million USD | 260.855% |
| electroCore, Inc. | -9.95 Million USD | 1068.78% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 1977.0% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -4760.633% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 1981.795% |
| IceCure Medical Ltd | -9.93 Million USD | 1070.827% |
| Inogen, Inc. | -103.56 Million USD | 193.119% |
| OrthoPediatrics Corp. | -9.26 Million USD | 1140.704% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 2748.778% |
| Spectral AI, Inc. | -3.5 Million USD | 2854.699% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 836.365% |
| MaxCyte, Inc. | -27.76 Million USD | 447.376% |
| NanoVibronix, Inc. | -3.27 Million USD | 3042.099% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 300.808% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 16850.178% |
| PAVmed Inc | 29.08 Million USD | -231.575% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -3042.842% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 669.349% |
| RxSight, Inc. | -6.68 Million USD | 1543.743% |
| SI-BONE, Inc. | 5.72 Million USD | -1585.754% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | -68.249% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -27298.295% |
| Cerus Corporation | 84.35 Million USD | -14.333% |
| Venus Concept Inc. | 74.3 Million USD | -29.799% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 1047.181% |
| LivaNova PLC | 62.53 Million USD | -54.228% |
| 908 Devices Inc. | -115.09 Million USD | 183.793% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 69.929% |
| Nemaura Medical Inc. | 9.92 Million USD | -871.706% |
| NeuroPace, Inc. | 54.33 Million USD | -77.489% |
| LENSAR, Inc. | -18.31 Million USD | 626.66% |
| Apyx Medical Corporation | -5.15 Million USD | 1972.297% |
| Cutera, Inc. | 288.3 Million USD | 66.548% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -1183.327% |
| BioSig Technologies, Inc. | 262 Thousand USD | -36709.924% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 320.037% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 1148.397% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 93.137% |
| Axonics, Inc. | -77.19 Million USD | 224.935% |
| Outset Medical, Inc. | 67.67 Million USD | -42.499% |
| IRIDEX Corporation | -4.28 Million USD | 2349.114% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 154.175% |
| IRadimed Corporation | -47.71 Million USD | 302.103% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 3287.112% |
| INVO Bioscience, Inc. | 8.45 Million USD | -1041.172% |
| Telesis Bio, Inc. | 32.63 Million USD | -195.517% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 3954.393% |
| Varex Imaging Corporation | 316.9 Million USD | 69.567% |
| Quipt Home Medical Corp. | 81.73 Million USD | -17.994% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 3566.643% |
| Pulmonx Corporation | -42.36 Million USD | 327.672% |
| Dynatronics Corporation | 6.2 Million USD | -1454.505% |
| Modular Medical, Inc. | -8.04 Million USD | 1299.229% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 2344.403% |
| Semler Scientific, Inc. | -57.13 Million USD | 268.811% |
| InMode Ltd. | -135.39 Million USD | 171.231% |
| Bruker Corporation | 891.3 Million USD | 89.18% |
| Cytosorbents Corporation | 4.18 Million USD | -2206.113% |
| DexCom, Inc. | 2.02 Billion USD | 95.244% |
| Align Technology, Inc. | -840.47 Million USD | 111.475% |
| Viveve Medical, Inc. | -13.81 Million USD | 798.197% |
| ZimVie Inc. | 450.41 Million USD | 78.588% |
| Movano Inc. | -5.86 Million USD | 1744.085% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 171.728% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 16850.178% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -4760.633% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 72.97% |
| Profound Medical Corp. | -18.17 Million USD | 630.527% |
| Insulet Corporation | 798.1 Million USD | 87.916% |
| enVVeno Medical Corporation | -2.21 Million USD | 4448.151% |
| Surmodics, Inc. | -12.01 Million USD | 902.747% |
| iCAD, Inc. | -21.2 Million USD | 554.722% |
| Nuwellis, Inc. | -2.81 Million USD | 3521.142% |
| Biotricity, Inc. | 23.09 Million USD | -317.629% |
| iRhythm Technologies, Inc. | 93.65 Million USD | -2.98% |
| Aethlon Medical, Inc. | -4.5 Million USD | 2242.364% |
| InspireMD, Inc. | -8.04 Million USD | 1298.782% |
| PAVmed Inc. | 29.08 Million USD | -231.575% |
| BIOLASE, Inc. | 11.34 Million USD | -750.159% |
| Beyond Air, Inc. | 6.22 Million USD | -1448.274% |
| FONAR Corporation | -14.66 Million USD | 757.619% |
| AxoGen, Inc. | 32.26 Million USD | -198.897% |
| Vivani Medical, Inc. | 42 Thousand USD | -229523.81% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 1004.879% |
| Inari Medical, Inc. | -7.16 Million USD | 1446.767% |
| UFP Technologies, Inc. | 40.77 Million USD | -136.528% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 2121.29% |
| Tenon Medical, Inc. | -1.25 Million USD | 7784.622% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 1367.973% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 908.649% |
| AdaptHealth Corp. | 2.21 Billion USD | 95.651% |
| Sintx Technologies, Inc. | 905 Thousand USD | -10556.575% |
| Quanterix Corporation | -132.95 Million USD | 172.536% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 3566.643% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 531.218% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 87.205% |
| TransMedics Group, Inc. | 121.13 Million USD | 20.384% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 468.38% |
| NeuroMetrix, Inc. | -1.49 Million USD | 6567.973% |
| Hyperfine, Inc. | -75.61 Million USD | 227.537% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 36.63% |
| Biomerica, Inc. | -3.38 Million USD | 2949.099% |
| Bone Biologics Corporation | -3.02 Million USD | 3286.513% |
| AVITA Medical, Inc. | -26.23 Million USD | 467.656% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 5345.943% |
| Silk Road Medical, Inc | 64.42 Million USD | -49.701% |